0 65

Cited 1 times in

Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

Authors
 J.-Y. Lee  ;  G. Kim  ;  Y.-H. Lee  ;  B.-W. Lee  ;  B.-S. Cha  ;  C.M. Nam  ;  E.S. Kang 
Citation
 Diabetes & Metabolism, Vol.45(1) : 83-85, 2019 
Journal Title
 Diabetes & Metabolism 
ISSN
 1262-3636 
Issue Date
2019
MeSH
Aged ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/etiology* ; Female ; Gliclazide/adverse effects* ; Humans ; Hypoglycemic Agents/adverse effects* ; Incidence ; Liver Neoplasms/epidemiology ; Liver Neoplasms/etiology* ; Male ; Middle Aged ; Risk ; Sulfonylurea Compounds/adverse effects*
Full Text
https://www.sciencedirect.com/science/article/pii/S1262363617304718
DOI
10.1016/j.diabet.2017.06.007
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Preventive Medicine and Public Health (예방의학교실) > 1. Journal Papers
Yonsei Authors
Kang, Eun Seok(강은석) ORCID logo https://orcid.org/0000-0002-0364-4675
Kim, Gyuri(김규리)
Nam, Jung Mo(남정모) ORCID logo https://orcid.org/0000-0003-0985-0928
Lee, Byung Wan(이병완) ORCID logo https://orcid.org/0000-0002-9899-4992
Lee, Yong Ho(이용호) ORCID logo https://orcid.org/0000-0002-6219-4942
Lee, Ji Yeon(이지연)
Cha, Bong Soo(차봉수) ORCID logo https://orcid.org/0000-0003-0542-2854
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/170945
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse